PaxVax: Reshaping Live Vaccines

An ideal vaccine for infectious diseases prevalent in developing countries would be cheap, oral, work in a single dose and not require refrigeration. PaxVax Inc. thinks its adenovirus serotype 4 vectors will do the trick.

For developing world vaccines, the company envisions partnering with non-profit product development partnerships (PDPs)for Phase II trials and creating non-profit manufacturing plants abroad...